United States Biotechnology & Medical Research

Third Harmonic Bio Inc (THRD)

Track

Ticker: THRD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Third Harmonic Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 8 Nov 2024
Value US$4,711,428.60 | Price 491.48 | Shares 15,983 (-17.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-12 2024-11-08 PlS Planned sale
Conner Edward R.

Chief Medical Officer

Officer
15,983 -17.1%
491.48
US$4,711,429 		15,983 -17.1% 491.48 US$4,711,429
2024-10-31 2024-10-29 S Sale
4.1
BVF PARTNERS L P/IL
94,359 +8.4%
402.19
US$19,846 		94,359 +8.4% 402.19 US$19,846
2024-10-31 2024-10-29 S Sale
4.1
BVF PARTNERS L P/IL
44,415 +25.9%
423.19
US$2,953,074 		44,415 +25.9% 423.19 US$2,953,074
2024-10-31 2024-10-29 S Sale
4.1
BVF PARTNERS L P/IL
538,420 -23.1%
14.30
US$7,699,406 		538,420 -23.1% 14.30 US$7,699,406
2024-10-30 2024-10-28 PlS Planned sale
Conner Edward R.

Chief Medical Officer

Officer
2,673 -100.0%
15.00
US$40,095 		2,673 -100.0% 15.00 US$40,095
2024-10-28 2024-10-28 PrS Proposed sale
EDWARD CONNER

Officer

Officer
4,790
13.15
US$62,988 		4,790 13.15 US$62,988
2024-09-20 2024-09-19 PlS Planned sale
Person Julie

CHIEF ADMINISTRATIVE OFFICER

Officer
9,497 -100.0%
14.29
US$135,685 		9,497 -100.0% 14.29 US$135,685
2024-09-20 2024-09-19 PlS Planned sale
Conner Edward R.

Chief Medical Officer

Officer
4,790 -100.0%
15.00
US$71,850 		4,790 -100.0% 15.00 US$71,850
2024-09-19 2024-09-19 PrS Proposed sale
EDWARD CONNER

Officer

Officer
4,790
13.50
US$64,665 		4,790 13.50 US$64,665
2024-09-20 2024-09-18 PlS Planned sale
Person Julie

CHIEF ADMINISTRATIVE OFFICER

Officer
503 -100.0%
14.00
US$7,042 		503 -100.0% 14.00 US$7,042
2024-09-18 2024-09-18 PrS Proposed sale
JULIE PERSON

Officer

Officer
10,000
12.75
US$127,500 		10,000 12.75 US$127,500
2024-06-28 2024-06-26 PlS Planned sale
Person Julie

CHIEF ADMINISTRATIVE OFFICER

Officer
10,000 -100.0%
12.46
US$124,569 		10,000 -100.0% 12.46 US$124,569
2024-06-26 2024-06-26 PrS Proposed sale
JULIE PERSON

Officer

Officer
10,000
12.54
US$125,400 		10,000 12.54 US$125,400
2024-06-10 2024-06-07 S Sale
3.4
Dittman Jennifer

Chief Development Oper Officer

Officer
494 -100.0%
14.17
US$7,000 		494 -100.0% 14.17 US$7,000
2024-05-22 2024-05-20 S Sale
3.4
Dittman Jennifer

Chief Development Oper Officer

Officer
1,042 -100.0%
14.00
US$14,588 		1,042 -100.0% 14.00 US$14,588
2024-05-22 2024-05-20 S Sale
3.4
Dittman Jennifer

Chief Development Oper Officer

Officer
1,042 -100.0%
14.00
US$14,588 		1,042 -100.0% 14.00 US$14,588
2024-05-20 2024-05-20 PrS Proposed sale
3.4
JENNIFER DITTMAN

Officer

Officer
1,536
13.87
US$21,297 		1,536 13.87 US$21,297
2024-05-17 2024-05-17 PrS Proposed sale
3.4
JENNIFER DITTMAN

Officer

Officer
23,578
14.23
US$335,515 		23,578 14.23 US$335,515
2024-05-20 2024-05-16 PlS Planned sale
3.4
Dittman Jennifer

Chief Development Oper Officer

Officer
23,578 -100.0%
14.04
US$331,066 		23,578 -100.0% 14.04 US$331,066
2024-05-10 2024-05-09 PlS Planned sale
Holles Natalie C.

CEO

Executive Director
20,222 -1.6%
12.18
US$246,300 		20,222 -1.6% 12.18 US$246,300
2024-05-10 2024-05-09 PlS Planned sale
Holles Natalie C.

CEO

Executive Director
20,222 -1.6%
12.18
US$246,300 		20,222 -1.6% 12.18 US$246,300
2024-04-15 2024-04-11 PlS Planned sale
Holles Natalie C.

CEO

Executive Director
13,558 -1.1%
12.19
US$165,214 		13,558 -1.1% 12.19 US$165,214
2024-04-11 2024-04-11 PrS Proposed sale
NATALIE HOLLES

Director; Officer

Executive Director
45,040
11.94
US$537,778 		45,040 11.94 US$537,778
2024-04-10 2024-04-10 PrS Proposed sale
2.2
ROBERT HO

Officer

Officer
23,130
11.08
US$256,280 		23,130 11.08 US$256,280
2024-04-08 2024-04-04 PlS Planned sale
Person Julie

CHIEF ADMINISTRATIVE OFFICER

Officer
1,107 -100.0%
10.00
US$11,070 		1,107 -100.0% 10.00 US$11,070
2024-04-04 2024-04-04 PrS Proposed sale
JULIE PERSON

Officer

Officer
1,107
9.31
US$10,306 		1,107 9.31 US$10,306
2023-12-07 2023-12-05 PlS Planned sale
Conner Edward R.

Chief Medical Officer

Officer
4,790 -100.0%
10.03
US$48,062 		4,790 -100.0% 10.03 US$48,062
2023-12-07 2023-12-05 PlS Planned sale
Person Julie

Chief Administrative Officer

Officer
12,863 -100.0%
10.30
US$132,484 		12,863 -100.0% 10.30 US$132,484
2023-12-05 2023-12-05 PrS Proposed sale
EDWARD CONNER

Officer

Officer
4,790
9.50
US$45,505 		4,790 9.50 US$45,505
2023-12-05 2023-12-05 PrS Proposed sale
JULIE PERSON

Officer

Officer
12,863
9.50
US$122,198 		12,863 9.50 US$122,198
2022-12-22 2022-12-20 B Purchase
4.1
BVF PARTNERS L P/IL
Large shareholder
9,597 +4.1%
4.11
US$39,430 		9,597 +4.1% 4.11 US$39,430
2022-12-22 2022-12-20 B Purchase
4.1
BVF PARTNERS L P/IL
Large shareholder
87,831 +5.2%
4.11
US$360,862 		87,831 +5.2% 4.11 US$360,862
2022-12-22 2022-12-20 B Purchase
4.1
BVF PARTNERS L P/IL
Large shareholder
116,635 +5.3%
4.11
US$479,207 		116,635 +5.3% 4.11 US$479,207
2022-09-21 2022-09-19 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
300,000 +5.5%
17.00
US$5,100,000 		300,000 +5.5% 17.00 US$5,100,000
2022-09-21 2022-09-19 B Purchase
2.9
Bonita David P
Non-Executive Director Large shareholder
300,000 +5.5%
17.00
US$5,100,000 		300,000 +5.5% 17.00 US$5,100,000
2022-09-19 2022-09-19 B Purchase
2.0
Atlas Venture Fund XI, L.P.
Large shareholder
300,000 +3.0%
17.00
US$5,100,000 		300,000 +3.0% 17.00 US$5,100,000
Explore more

More insider trading research around Third Harmonic Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America